Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Abstract Objectives The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. Patients an...

Full description

Bibliographic Details
Main Authors: Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:BJUI Compass
Subjects:
acceptability
high risk
hyperthermic intravesical chemotherapy
intravesical treatment
mitomycin C
non‐muscle‐invasive bladder cancer
Online Access:https://doi.org/10.1002/bco2.203

Internet

https://doi.org/10.1002/bco2.203

Similar Items